跳至主要内容
临床试验/NL-OMON47211
NL-OMON47211招募中不适用

on-invasive diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease using markers and imaging techniques - NASH: non-invasive diagnostic markers and imaging

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - NAFLD proven by imaging
  • - Age 18-65 years

排除标准

  • - Incompetent to understand and/or sign the informed consent.
  • - Ethanol consumption exceeding more than 14 standard beverages per week for males and more than 7 standard beverages per week for female.
  • - Causes for secondary hepatic fat accumulation such as significant alcohol consumption, medications, Wilson*s disease, viral infections, starvation or parenteral nutrition, among others, and conditions associated with microvesicular steatosis
  • - Unwilling to collect biosamples.
  • - Pregnancy and breastfeeding.
  • - Diagnosis of liver cirrhosis and/or hepatocellular carcinoma.
  • - Current diagnosis of extrahepatic malignancie(s) or prior diagnosis within last 5 years.
  • - Diagnosis of chronic inflammatory disease (i.e. inflammatory bowel disease, rheumatoid arthritis, inflammatory lung disease, severe infectious diseases), other than NAFLD/NASH
  • - Chronic use of immunosuppressants (e.g. biologicals, prednisolone, azathioprine)

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验